Tags : Immune-Mediated Inflammatory Diseases

IMIDomics Collaborates with Gossamer Bio to Develop Therapies for Treating

Shots: The companies collaborates on multiple projects, being the first for inflammatory bowel disease(IBD) to develop and discover therapies for treating Immune-Mediated Inflammatory Diseases (IMIDs) The focus of the collaboration will allow Gossamer’s immunology research and development team to utilize IMIDomics’ unique clinical and molecular patient database for product discovery and development strategy IMIDomics’ platform […]Read More